Inactive Instrument

Iqvia Holdings Inc Stock price Nyse

Equities

US74876Y1010

Biotechnology & Medical Research

Sales 2024 * 15.54B Sales 2025 * 16.67B Capitalization 46.03B
Net income 2024 * 1.33B Net income 2025 * 1.58B EV / Sales 2024 * 3.74 x
Net Debt 2024 * 12.07B Net Debt 2025 * 11.65B EV / Sales 2025 * 3.46 x
P/E ratio 2024 *
34.6 x
P/E ratio 2025 *
29 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 69.76%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Iqvia Holdings Inc

Managers TitleAgeSince
Chief Executive Officer 62 16-10-02
Director of Finance/CFO 63 20-07-31
Chief Operating Officer 51 17-06-30
Members of the board TitleAgeSince
Director/Board Member 67 16-10-02
Director/Board Member 68 17-07-26
Chief Executive Officer 62 16-10-02
More insiders
Iqvia Holdings Inc. is one of the world's leading companies specializing in information, analytics, research and healthcare services based on technology solutions. Net sales break down by activity as follows: - development of contract research and clinical development solutions and services (54.5%): helping biopharmaceutical companies, medical researchers and healthcare professionals optimize their clinical studies, develop new therapeutic classes, identify treatment needs and assess the efficacy of pharmaceuticals with a view to improving clinical and scientific outcomes; - development of technology and analytics solutions (39.9%): services related to information, analysis, strategic consulting, marketing studies and short-term healthcare-market studies, business processes outsourcing, and management of medical-administrative databases, all aimed at optimizing the performance and commercial strategies of pharmaceutical companies and health workers; - integrated services (5.6%): development and implementation of customized solutions and customer engagement programs, healthcare services, scientific and medical services, etc. Net sales are distributed geographically as follows: Americas (49.4%), Europe and Africa (31.4%) and Asia/Pacific (19.2%).
Calendar
Related indices
More about the company
  1. Stock
  2. Equities
  3. Stock Iqvia Holdings Inc.
  4. Stock Iqvia Holdings Inc - Nyse